Understanding of molecular events associated with tumor microenvironment in pancreatic cancer (PC) is an active area of research especially because of the rich desmoplasia seen in human PC. Desmoplasia is contributed by several cell types including cancer-associated fibroblast (CAF) and stellate cells (PSCs), which are believed to play critical roles in conferring aggressiveness to PC. The aberrant expression of microRNAs (miRNAs) in PSCs and CAF cells appears to play a pivotal role in the development and progression of PC. In this study, expression analysis of miR-21/miR-221 in conditioned media derived from PSCs/CAF cells, and from PSCs/CAF cells showed up-regulation of both miRNAs compared to MIAPaCa-2 PC cells. In addition, miR-21 expre...
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cau...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...
Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers. A major hallmark of ...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
<div><p>Introduction</p><p>Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the secon...
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third foremost ...
Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause of U.S. can...
Pancreatic cancer is one of the most fatal malignancies with increasing incidence and high mortality...
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cau...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...
Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers. A major hallmark of ...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic stellate cells (PSCs) are the key precursor cells for cancer-associated fibroblasts (CAFs...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
<div><p>Introduction</p><p>Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the secon...
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third foremost ...
Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause of U.S. can...
Pancreatic cancer is one of the most fatal malignancies with increasing incidence and high mortality...
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cau...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause...